CN107151260B - 一种抗肿瘤活性化合物的制备方法 - Google Patents
一种抗肿瘤活性化合物的制备方法 Download PDFInfo
- Publication number
- CN107151260B CN107151260B CN201710524848.8A CN201710524848A CN107151260B CN 107151260 B CN107151260 B CN 107151260B CN 201710524848 A CN201710524848 A CN 201710524848A CN 107151260 B CN107151260 B CN 107151260B
- Authority
- CN
- China
- Prior art keywords
- methanol
- glucoside
- glucose
- substituted
- dichloromethane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001875 compounds Chemical class 0.000 title abstract description 12
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 230000000259 anti-tumor effect Effects 0.000 title abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 45
- 229930182478 glucoside Natural products 0.000 claims abstract description 25
- 150000008131 glucosides Chemical class 0.000 claims abstract description 25
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 19
- 239000008103 glucose Substances 0.000 claims abstract description 17
- 229930014626 natural product Natural products 0.000 claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 14
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 12
- SMFFZOQLHYIRDA-UHFFFAOYSA-N 3,4-dimethoxyphenol Chemical compound COC1=CC=C(O)C=C1OC SMFFZOQLHYIRDA-UHFFFAOYSA-N 0.000 claims abstract description 10
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 claims abstract description 8
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims abstract description 8
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims abstract description 7
- 125000003147 glycosyl group Chemical group 0.000 claims abstract description 7
- LNTHITQWFMADLM-UHFFFAOYSA-N anhydrous gallic acid Natural products OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims abstract description 4
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 69
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 11
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- 229930182470 glycoside Natural products 0.000 claims description 7
- 150000002338 glycosides Chemical class 0.000 claims description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- 238000010898 silica gel chromatography Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 3
- -1 46.9mmol Chemical compound 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 3
- 230000021736 acetylation Effects 0.000 claims description 3
- 238000006640 acetylation reaction Methods 0.000 claims description 3
- 239000003729 cation exchange resin Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000012074 organic phase Substances 0.000 claims description 2
- 239000000047 product Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229920006395 saturated elastomer Chemical class 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 239000002904 solvent Substances 0.000 abstract description 3
- 239000007858 starting material Substances 0.000 abstract description 2
- 238000006555 catalytic reaction Methods 0.000 abstract 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000002194 synthesizing effect Effects 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710524848.8A CN107151260B (zh) | 2017-06-30 | 2017-06-30 | 一种抗肿瘤活性化合物的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710524848.8A CN107151260B (zh) | 2017-06-30 | 2017-06-30 | 一种抗肿瘤活性化合物的制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107151260A CN107151260A (zh) | 2017-09-12 |
| CN107151260B true CN107151260B (zh) | 2020-09-15 |
Family
ID=59795113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710524848.8A Active CN107151260B (zh) | 2017-06-30 | 2017-06-30 | 一种抗肿瘤活性化合物的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107151260B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108929857B (zh) * | 2017-05-26 | 2021-10-29 | 中国海洋大学 | 一种柳珊瑚来源的海洋真菌及其在制备拓扑异构酶i抑制剂中的应用 |
-
2017
- 2017-06-30 CN CN201710524848.8A patent/CN107151260B/zh active Active
Non-Patent Citations (3)
| Title |
|---|
| "3-取代槲皮素衍生物的合成研究";李化军;《中国优秀博硕士学位论文全文数据库（硕士）医药卫生科技辑》;20041215(第04期);E079-7 * |
| "Synthesis of tyrosyl-DNA phosphodiesterase I inhibitors";Sagar D. Nale，等;《Tetrahedron Letters》;20160506;第57卷;2652–2654 * |
| Sagar D. Nale，等."Synthesis of tyrosyl-DNA phosphodiesterase I inhibitors".《Tetrahedron Letters》.2016,第57卷2652–2654. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107151260A (zh) | 2017-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Synthesis of carbohydrate building blocks via regioselective uniform protection/deprotection strategies | |
| CN103122012B (zh) | 用于制备磺达肝癸钠的化合物及其制备方法、磺达肝癸钠的制备方法 | |
| WO2012113404A1 (en) | Novel glycosyl phosphites | |
| US4683297A (en) | Process for the preparation of glycosides | |
| CN107286207B (zh) | 一种龙胆二糖的合成方法 | |
| CN106117283A (zh) | 一种5‑羟甲基糠醛参与的2,3‑不饱和糖苷的合成方法 | |
| CN107151260B (zh) | 一种抗肿瘤活性化合物的制备方法 | |
| CN108892740B (zh) | 一种3,6位支化葡聚六糖的合成方法 | |
| CN103476782A (zh) | N-取代的甘露糖胺衍生物及其制备方法和用途 | |
| CN110903333A (zh) | 一种糖苷及其衍生物的制备方法 | |
| EP0882733B1 (en) | Acylating agent and a method of producing thereof | |
| CN102993256B (zh) | 一种选择性脱除全三甲基硅基保护糖的伯位三甲基硅基的方法 | |
| CN104387426A (zh) | 一种区域选择性合成6-o-丙烯酰基糖类衍生物的方法 | |
| CN112358514B (zh) | 一种熊果苷的合成工艺 | |
| US3723506A (en) | Oxidation of sugars | |
| Yang et al. | Synthesis of a glucoheptaose-the repeating unit of lentinan | |
| CN107056849B (zh) | 一种全乙酰基保护α-2,6-二脱氧葡萄糖-O-糖苷的制备方法 | |
| Mitra et al. | Linear synthesis of the hexasaccharide related to the repeating unit of the O-antigen from Shigella flexneri serotype 1d (I: 7, 8) | |
| CN104650160A (zh) | 卡培他滨关键中间体1,2,3-o-三乙酰基-5-脱氧-d-核糖的合成新方法 | |
| TAKAMURA et al. | Chemical Modification of Lactose. VIII. Studies on the Reactivities of the Secondary Hydroxyl Groups in 1, 6-Anhydro-4', 6'-O-benzylidene-β-lactose by Selective p-Toluenesulfonylation | |
| CN114736315B (zh) | 香菇多糖核心片段β-（1→6）支链β-（1→3）主链的七糖合成方法 | |
| CN104372052A (zh) | 一种化学法合并酶法制备糖苷类化合物的方法 | |
| CN110016066B (zh) | 一种i型n-聚糖天线的合成方法 | |
| CN110698523B (zh) | 一种化学合成β-熊果苷的方法 | |
| CN114891049B (zh) | 基于邻炔基苄醚类糖基供体的高效糖基化方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 257093 Binhai New District, Lijin County, Dongying City, Shandong Province (Diaokou Township Residence) Applicant after: SHANDONG DOYE PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Applicant after: WEIFANG HONGNUO HETAI NEW MATERIAL SCIENCE AND TECHNOLOGY Co.,Ltd. Address before: 257093 Binhai New District, Lijin County, Dongying City, Shandong Province (Diaokou Township Residence) Applicant before: DONGYING DAOYI BIOLOGICAL MEDICINE TECHNOLOGY Co.,Ltd. Applicant before: WEIFANG HONGNUO HETAI NEW MATERIAL SCIENCE AND TECHNOLOGY Co.,Ltd. |
|
| CB02 | Change of applicant information | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20200812 Address after: 261053 Shandong city of Weifang province Baotong Street No. 7166 Applicant after: WEIFANG MEDICAL University Applicant after: SHANDONG DOYE PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Applicant after: Shandong Daozhen Pharmaceutical Technology Co.,Ltd. Applicant after: WEIFANG HONGNUO HETAI NEW MATERIAL SCIENCE AND TECHNOLOGY Co.,Ltd. Address before: Dongying City, Shandong province 257093 Binhai Lijin County (diaokouhe Township resident) Applicant before: SHANDONG DOYE PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Applicant before: WEIFANG HONGNUO HETAI NEW MATERIAL SCIENCE AND TECHNOLOGY Co.,Ltd. |
|
| TA01 | Transfer of patent application right | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of antitumor compound Effective date of registration: 20210224 Granted publication date: 20200915 Pledgee: Industrial and Commercial Bank of China Limited Shouguang sub branch Pledgor: Shandong Daozhen Pharmaceutical Technology Co.,Ltd. Registration number: Y2021980001298 |
|
| CP01 | Change in the name or title of a patent holder |
Address after: 261053 No. 7166 Baotong West Street, Weifang City, Shandong Province Patentee after: WEIFANG MEDICAL University Patentee after: Shandong Daohe Pharmaceutical Co.,Ltd. Patentee after: Daohe (Weifang) Pharmaceutical Technology Co.,Ltd. Patentee after: WEIFANG HONGNUO HETAI NEW MATERIAL SCIENCE AND TECHNOLOGY Co.,Ltd. Address before: 261053 No. 7166 Baotong West Street, Weifang City, Shandong Province Patentee before: WEIFANG MEDICAL University Patentee before: SHANDONG DOYE PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Patentee before: Shandong Daozhen Pharmaceutical Technology Co.,Ltd. Patentee before: WEIFANG HONGNUO HETAI NEW MATERIAL SCIENCE AND TECHNOLOGY Co.,Ltd. |
|
| CP01 | Change in the name or title of a patent holder | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211124 Granted publication date: 20200915 Pledgee: Industrial and Commercial Bank of China Limited Shouguang sub branch Pledgor: Shandong Daozhen Pharmaceutical Technology Co.,Ltd. Registration number: Y2021980001298 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of antitumor active compound Effective date of registration: 20211126 Granted publication date: 20200915 Pledgee: Industrial and Commercial Bank of China Limited Shouguang sub branch Pledgor: Daohe (Weifang) Pharmaceutical Technology Co.,Ltd. Registration number: Y2021980013408 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221019 Granted publication date: 20200915 Pledgee: Industrial and Commercial Bank of China Limited Shouguang sub branch Pledgor: Daohe (Weifang) Pharmaceutical Technology Co.,Ltd. Registration number: Y2021980013408 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20170912 Assignee: Shandong Xindao Pharmaceutical Technology Co.,Ltd. Assignor: Shandong Daohe Pharmaceutical Co.,Ltd. Contract record no.: X2022980019300 Denomination of invention: Preparation of an anti-tumor active compound Granted publication date: 20200915 License type: Common License Record date: 20221024 |
|
| EE01 | Entry into force of recordation of patent licensing contract |